STOCK TITAN

DENTSPLY SIRONA (XRAY) CEO has 4,095 shares withheld to cover RSU taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. President and CEO Daniel T. Scavilla reported a routine tax-related share disposition. On May 22, 2026, 4,095 shares of common stock were withheld at $10.21 per share to cover taxes tied to vesting of his Restricted Stock Units and related dividend equivalent units.

After this withholding, Scavilla directly holds 157,754 shares of DENTSPLY SIRONA common stock. The transaction reflects tax withholding, not an open-market sale or discretionary trade.

Positive

  • None.

Negative

  • None.
Insider Scavilla Daniel T
Role President, CEO & Member of BOD
Type Security Shares Price Value
Tax Withholding Common Stock 4,095 $10.21 $42K
Holdings After Transaction: Common Stock — 157,754 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares withheld for taxes 4,095 shares Common stock withheld on May 22, 2026
Withholding price $10.21 per share Value used for tax-withholding shares
Shares held after transaction 157,754 shares Direct common stock ownership after withholding
Restricted Stock Units financial
"vesting of the reporting person's Restricted Stock Units and dividend equivalent units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalent units financial
"Restricted Stock Units and dividend equivalent units previously reported in Table I"
Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Form 4 regulatory
"previously reported in Table I."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Scavilla Daniel T

(Last)(First)(Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NORTH CAROLINA 28277

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President, CEO & Member of BOD
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/22/2026F4,095(1)D$10.21157,754D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Daniel T. Scavilla05/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) CEO Daniel Scavilla report?

Daniel T. Scavilla reported a tax-related share disposition. On May 22, 2026, 4,095 DENTSPLY SIRONA common shares were withheld to cover taxes on vesting of his Restricted Stock Units and related dividend equivalent units, as reflected in his Form 4 filing.

Was the DENTSPLY SIRONA (XRAY) CEO’s Form 4 transaction an open-market sale?

No, it was not an open-market sale. The 4,095 shares were withheld by the company to satisfy tax obligations arising from the vesting of Restricted Stock Units and dividend equivalent units, which is a routine, non-discretionary tax-withholding transaction.

At what price were DENTSPLY SIRONA (XRAY) shares withheld for the CEO’s taxes?

The withheld shares were valued at $10.21 per share. This price was used to calculate the number of shares (4,095) needed to satisfy Daniel T. Scavilla’s tax liability related to his Restricted Stock Unit vesting event.

How many DENTSPLY SIRONA (XRAY) shares does CEO Daniel Scavilla hold after this Form 4?

Following the tax-withholding transaction, Daniel T. Scavilla directly holds 157,754 shares of DENTSPLY SIRONA common stock. This post-transaction balance is disclosed in the Form 4 as the total shares beneficially owned after the reported disposition.

What triggered the DENTSPLY SIRONA (XRAY) CEO’s tax-withholding share disposition?

The transaction was triggered by the vesting of the CEO’s Restricted Stock Units and associated dividend equivalent units. To cover the resulting tax liability, 4,095 common shares were withheld, as described in the Form 4 footnote explaining the nature of the disposition.